Clinical Trials Browser

Phase 2 × Not yet recruiting × Olanzapine × Clear all

NCT06554613 2024-08-15

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung